Redox secures Dow agency deal and Morningstar sets AUD 4.40 for Redox stock

Published on 10/14/2026 at 01:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Morningstar sees 6% fiscal 2027 growth for Redox stock on October 8, 2026. FY 2026 sales rose 6.90% to AUD 1.33 billion.

Dow agency and analyst value

Redox was appointed Dow's agent for DOW Latex Powders on October 5, 2026.
Morningstar retained a 6.00 percent fiscal 2027 revenue growth forecast on October 8, 2026.
Redox stock was last at AUD 3.52 on the ASX on October 13, 2026.
Morningstar set fair value at AUD 4.40 on October 8, 2026.

Redox, AU0000284895, Illustration mit AI erstellt.

Redox Limited (AU0000284895) secured a new distribution role on October 5, 2026, when it was appointed Dow's agent for DOW Latex Powders in Australia and New Zealand. On October 8, 2026, Morningstar set a fair value of AUD 4.40 for Redox stock, keeping the valuation debate tied to growth and margin resilience.

Three milestones shape the story

On August 20, 2026, Redox reported fiscal 2026 sales revenue of AUD 1.33 billion, up 6.90 percent, while net profit after tax reached AUD 92.00 million, up 19.20 percent, according to Quartr.

On October 7, 2026, first-quarter fiscal 2027 selling prices were 9.00 percent higher than a year earlier while volumes were flat, according to Morningstar. The same report said gross profit margin exceeded the 22.40 percent achieved in fiscal 2026.

On October 5, 2026, Redox said the Dow appointment covered DOW Latex Powders for construction chemical manufacturers in Australia and New Zealand, according to Redox. The product range is intended for dry-mix construction formulations, adding a defined construction-materials application to Redox's broad chemicals distribution portfolio.

What does the valuation assume?

Morningstar retained a fiscal 2027 revenue growth forecast of 6.00 percent and a gross profit margin estimate of 22.00 percent on October 8, 2026, according to Morningstar. Its counterweight is cost pressure: the report cited weaker customer quantities, freight costs and the risk that lower-margin US growth could weigh on group margins.

That makes the AUD 4.40 fair value dependent on continued price growth and disciplined product mix rather than volume expansion alone. Redox's fiscal 2026 North American sales grew 33.80 percent to more than AUD 100.00 million, while Australian sales increased 6.10 percent to AUD 1.12 billion, according to Quartr.

Next reporting date is February 18

Redox's next reported earnings event is listed for February 18, 2027, for the first half of fiscal 2027, according to Quartr. The date gives investors a defined checkpoint for testing whether the first-quarter price gains are translating into sustained revenue and margin performance.

Last ASX price before publication

Redox was last at AUD 3.52 on the ASX on October 13, 2026 at 5:10 a.m. UTC, according to the latest quoted market data. The figure sits below Morningstar's AUD 4.40 fair value, while the company's reported fiscal 2026 margin and fiscal 2027 price growth provide the main operating measures for the next update.

Market context: Market report S&P/ASX 200.